QA: Gelesis Holdings INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001805087_2023_Gelesis_Holdings_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001805087, Gelesis Holdings INC

  xvar xval
0 AssetsCurrent 23,496,000
1 IntangibleAssetsNetIncludingGoodwill 13,413,000
2 PropertyPlantAndEquipmentNet 59,335,000
3 remainder_Assets 7,080,000
4 LiabilitiesCurrent 78,346,000
5 LiabilitiesNoncurrent 1,865,000
6 remainder_Liabilities 35,579,000
7 CostOfGoodsAndServicesSold 27,558,000
8 SellingGeneralAndAdministrativeExpense 99,135,000
9 ResearchAndDevelopmentExpense 18,613,000
10 remainder_Expenses -3,346,000
11 remainder_Revenues 25,767,000
12 remainder_NetIncome 60,413,000
13 remainder_ComprehensiveNetIncome -115,000
  yvar yval
0 Assets 103,324,000
1 Liabilities 115,790,000
2 Expenses 141,960,000
3 Revenues 25,767,000
4 StockholdersEquity -12,466,000
5 NetIncome -55,780,000
6 ComprehensiveNetIncome -55,837,500
7 BaseVar 223,684,500
8 EconomicCapitalRatiobeforeLimitedLiability -0.758
9 EconomicCapitalRatio 1.35

Edgar->Model Mapping

Feature Distribution

Change over Time